Ibrutinib Market Size and Forecast: 2024 Industry Trends and Projections
Ibrutinib is a medicine that inhibits Bruton's tyrosine kinase (BTK), a protein essential for the proliferation of cancer cells, to effectively treat certain blood malignancies.